SEC settles with ex-InterMune controller over tip to friend

June 7 (Reuters) - A former executive of InterMune Inc has agreed to pay $616,000 to settle claims by the U.S. Securities and Exchange Commission that he illegally tipped a friend in 2010 of the status of a regulatory review for its drug Esbriet.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.